Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.
Feature | Coronavirus (COVID-19)
NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients

December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...

Home December 23, 2020
Home
The stent struts of the Biotronik Orsiro stent.
News | Stents
New Stent Kink Resistance Testing Proposed in ASTM International Standard

December 21, 2020 – A proposed ASTM International standard will answer the need for a standardized test method that ...

Home December 21, 2020
Home
A peripheral artery disease (PAD) patient CT scan showing blockages in the femoral arteries in the legs with collateral flow in the leg on the right.
News | Stents Bioresorbable
First-In-Human Use Reported for Bioresorbable Efemoral Vascular Scaffold System

December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular ...

Home December 16, 2020
Home
Videos | FFR Technologies
VIDEO: Example of the Medis QFR Angiography Image Derived FFR System

This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow ...

Home December 16, 2020
Home
Videos | Robotic Systems
VIDEO: Corindus CorPath Robotic PCI System For The Cardiac Cath Lab

This is an example of the Siemens Corindus CorPath Cath lab robotic system being used for a percutaneous coronary ...

Home December 16, 2020
Home
The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.
News | FFR Technologies
Acist Medical Partners With Medis to Distribute Angiography Image Derived FFR Quantification System

December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging to ...

Home December 16, 2020
Home
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.
News | Renal Denervation
FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System

December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to ...

Home December 09, 2020
Home
GE Healthcare is introducing a new, smaller and lighter weight robotic driven angiography system for image guided therapy, the Allia IGS 7 angiography system. #RSNA20 #RSNA2020
News | Angiography
GE Introduces Robotic Angiography Gantry That Addresses Ergonomic Issues

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Home December 01, 2020
Home
COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States. #DAIC
Feature | Cardiovascular Business | Dave Fornell, Editor
Most Popular Cardiology Technology Content in November 2020

December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home December 01, 2020
Home
A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve repair (TMVR) with use of the Baylis VersaCross RF Transseptal Solution, reporting guide delivery from femoral access in under 7.5 minutes.
News | Hemodynamic Monitoring Systems
Study Finds TMVR Procedural Efficiency Using the VersaCross RF Transseptal Solution

December 1, 2020 — A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve ...

Home December 01, 2020
Home
One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT drug-eluting stent (DES), to the Xience or Promus Durable Polymer DES showed it was equivalent in clinical performance to the market-leading DES. The results were presented at the 2020 American Heart Association (AHA) Scientific Session. #AHA2020 #AHA20 #AHA
News | Stents
Biodegradable Drug Eluting Coronary Stent Noninferior to Xience or Promus Durable Polymer Stents

November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT ...

Home November 24, 2020
Home
Feature | Heart Valve Technology
TAVR Is Now Dominant Form of Aortic Valve Replacement in the United States

November 17, 2020 — Since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more ...

Home November 17, 2020
Home
oston Scientific Corp. announced today it is immediately retiring the entire Lotus Edge transcatheter aortic valve replacement (TAVR) system. It also initiated a global, voluntary recall of all unused inventory of the Lotus Edge due to complexities associated with the product delivery system. 
Feature | Heart Valve Technology | Dave Fornell, Editor
Boston Scientific Pulls Lotus Edge TAVR Valve Off The Market

November 17, 2020 — Boston Scientific Corp. announced today it is immediately retiring the entire Lotus Edge ...

Home November 17, 2020
Home
Women’s Heart Attack Research Program (HARP) shows combining OCT and cardiac MRI can detect the underlying cause of heart attack in women who did not have blocked arteries
News | Cardiac Imaging
OCT Combined with MRI Can Identify Cause of Unexplained Heart Attacks in Women

November 17, 2020 — Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women ...

Home November 17, 2020
Home
Omega-3 fish oil supplements did not help patients after a heart attack in AHA 2020 study. #AHA #AHA20 #AHA2020. Getty Images
News | Pharmaceuticals
Omega-3s Do Not Reduce Cardiac Events in Recent Heart Attack Survivors

November 17, 2020 — A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary ...

Home November 17, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now